These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa. Hauser RA; Rascol O; Korczyn AD; Jon Stoessl A; Watts RL; Poewe W; De Deyn PP; Lang AE Mov Disord; 2007 Dec; 22(16):2409-17. PubMed ID: 17894339 [TBL] [Abstract][Full Text] [Related]
11. [Effects and side effects of levodopa in parkinsonism - results of a collaborative study. (3) Side effects of levodopa]. Mizuno Y Rinsho Shinkeigaku; 1976 Dec; 16(12):874-6. PubMed ID: 1035529 [No Abstract] [Full Text] [Related]
12. A nation-wide collaborative study on the long-term effects of bromocriptine in patients with Parkinson's disease. First interim report in Japan. Nakanishi T; Mizuno Y; Goto I; Iwata M; Kanazawa I; Kowa H; Mannen T; Nishitani H; Ogawa N; Takahashi A Eur Neurol; 1988; 28 Suppl 1():3-8. PubMed ID: 3378560 [TBL] [Abstract][Full Text] [Related]
13. [Complications of long-term levodopa therapy in Parkinson's disease]. Kostić V; Nikolić M Srp Arh Celok Lek; 1984 Sep; 112(9):975-84. PubMed ID: 6531729 [No Abstract] [Full Text] [Related]
14. [Multivariate analysis of the problems of long-term levodopa therapy in Parkinson's disease]. Nakamura Y; Yoshinaga J; Endo S; Hikiji A Rinsho Shinkeigaku; 1997 Jun; 37(6):469-75. PubMed ID: 9366172 [TBL] [Abstract][Full Text] [Related]
15. [The treatment of Parkinson disease using the combination bromocriptine and levodopa]. Dufresne JJ Rev Med Suisse Romande; 1990 Jun; 110(6):559-64. PubMed ID: 2367793 [No Abstract] [Full Text] [Related]
16. Low-dose, slow-increase bromocriptine in patients with progressive Parkinson's disease and complications of levodopa therapy. Stern MB; Vernon GM; Gollomp SM; Hurtig HI Bull Clin Neurosci; 1986; 51():52-6. PubMed ID: 3455244 [TBL] [Abstract][Full Text] [Related]
17. Development of two malignant melanomas during administration of levodopa. Przybilla B; Schwab U; Landthaler M; Braun-Falco O Acta Derm Venereol; 1985; 65(6):556-7. PubMed ID: 2420127 [TBL] [Abstract][Full Text] [Related]
18. Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976-1990. Van Gerpen JA; Kumar N; Bower JH; Weigand S; Ahlskog JE Arch Neurol; 2006 Feb; 63(2):205-9. PubMed ID: 16476808 [TBL] [Abstract][Full Text] [Related]
19. [Long-term problems of levodopa therapy in Parkinson disease]. Albani C; Asper R; Baumgartner G Schweiz Med Wochenschr; 1987 Mar; 117(10):347-53. PubMed ID: 3105050 [TBL] [Abstract][Full Text] [Related]
20. [Tiapride in persistent dyskinesias following long-term L-dopa for parkinsonism]. Arlazoroff A; Flechtir S; Goldexberg E; Bleicher Z; Barber Y Harefuah; 1985 Mar; 108(5):227-9. PubMed ID: 4007677 [No Abstract] [Full Text] [Related] [Next] [New Search]